The effects of ritonavir and lopinavir/ritonavir on the pharmacokinetics of a novel CCR5 antagonist, aplaviroc, in healthy subjects

類似資料

• Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects
  著者:: Adkison, Kimberly K., 等
  出版事項: (2005)
• Virologic Failure in Therapy-Naïve Subjects on Aplaviroc plus Lopinavir-Ritonavir: Detection of Aplaviroc Resistance Requires Clonal Analysis of Envelope
  著者:: Kitrinos, Kathryn M., 等
  出版事項: (2009)
• Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects
  著者:: Kaufmann, Priska, 等
  出版事項: (2015)
• Assessment of the Pharmacokinetic Interaction between Eltrombopag and Lopinavir-Ritonavir in Healthy Adult Subjects
  著者:: Wire, Mary B., 等
  出版事項: (2012)
• Lopinavir/ritonavir population pharmacokinetics in neonates and infants
  著者:: Urien, Saik, 等
  出版事項: (2011)